Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950103-25-010208
Filing Date
2025-08-12
Accepted
2025-08-12 17:10:03
Documents
14
Effectiveness Date
2025-08-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 dp232903_s8.htm S-8 42208
2 EXHIBIT 5 dp232903_ex0500.htm EX-5 33049
3 EXHIBIT 23.2 dp232903_ex2302.htm EX-23.2 1923
4 EX-FILING FEES dp232903_exfilingfees.htm   iXBRL EX-FILING FEES 13619
  Complete submission text file 0000950103-25-010208.txt   210477

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT dp232903_exfilingfees_htm.xml XML 4854
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289543 | Film No.: 251207808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)